Number of Shares
4.21 Mil
Current Holdings Value*
$51.75 Mil
% of Portfolio
5.26%
Total Estimate Gain
$-26.56 Mil
% of Total Estimate Gain
-18.95%

Eversept Partners, LP's Syndax Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Eversept Partners, LP held 4.21 Mil shares of Syndax Pharmaceuticals Inc(SNDX), totaling $51.75 Mil. This investment constitutes 5.26% of their stock portfolio, and Eversept Partners, LP now holds 4.9% of the outstanding Syndax Pharmaceuticals Inc(SNDX) stock.

The initial trade took place in 2022Q2. And since then Eversept Partners, LP has made 9 purchases of SNDX, at an average price of $17.01, for a total of 8.24 Mil shares. In addition, there have been 3 sales at an average price of $17.41 for 4.03 Mil shares. Based on historical transaction data and SNDX's current price of $10.31, Eversept Partners, LP's estimated gain on his SNDX holdings is $-26.56 Mil, reflecting a -18.95% gain to date.

Eversept Partners, LP SNDX ($10.31) Holding Chart

Eversept Partners, LP SNDX ($10.31) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1